STAT+: Why health AI pilots in Utah may be on a collision course with the FDA
Reported by STAT News · all stories from statnews.com
Editorial digest
Pilot programs for AI in health within Utah could potentially encounter issues with existing FDA regulations. This piece explores the potential for conflict between state-level innovation and federal oversight.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at STAT News →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom10/8/2026
STAT+: AI for breast cancer risk prediction goes DTC, regulatory cloud over Utah sandbox, and AI psychosis
AI for breast cancer risk is now direct-to-consumer; regulatory concerns and AI-induced psychosis are also discussed.
- Trusted health newsroom8/24/2026
STAT+: FDA digital health leader promises generative AI regulatory guidance is coming
FDA digital health head confirms generative AI regulatory guidelines are in development.
- Trusted health newsroom9/14/2026
STAT+: How $500 explains Republican health policy, and the GLP-1 Rx wave
A specific financial figure illuminates Republican health policy and the rise of GLP-1 prescriptions.
- Trusted health newsroom10/14/2026
STAT+: Lobbyists and trade groups fight to shape how states regulate medical AI
Industry representatives are working to influence state-level medical artificial intelligence rules.
- Trusted health newsroom10/15/2026
STAT+: ‘AI sandboxes’ are all the rage. Advocates scramble to control their future
Industry experts are working to influence the development of regulatory frameworks for artificial intelligence innovation zones.
- Trusted health newsroom10/15/2026
Opinion: MyChart said I could opt out of sharing my health data. Figuring out how was maddening
An opinion piece describes difficulties in opting out of health data sharing through MyChart.